echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Painful shingles "quess" - shingles vaccine "out of the sky"! 10 questions 10 answers, tell all about ta!

    Painful shingles "quess" - shingles vaccine "out of the sky"! 10 questions 10 answers, tell all about ta!

    • Last Update: 2020-09-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Read: Can the Shingles Vaccine Bring New Hope to Patients? At the beginning of July, the star of shingles- shingles vaccine "landed" in Beijing and Shanghai! That's great news! Why do you say that? Because there's a pain called shingles... Speaking of shingles, I believe we are no strangers.
    herpes is caused by chickenpox-shingles virus and is a common disease in dermatology.
    because of its good hair in the chest, waist, so commonly known as "lumbar dragon", Chinese medicine called it "tangled waist fire Dan", its rash like a snake, also known as "snake string sores."
    shingles, in addition to skin damage, is often accompanied by neuropathic pain.
    this is specific to older people, immunosuppression or immunodeficiency patients, once "entangled", often painful.
    , with age and the decline of the body's immune function, the incidence of shingles increased, seriously affecting the quality of life of patients.
    you swollen? Can you only put up with it in silence? The main methods of shingles treatment are antiviral therapy, glucoticoid therapy, neuropathy treatment, local treatment, physiotherapy, shingles after-effect nerve pain therapy, etc.
    you pre-emption? It's painful to be treated after being entangled... Bingo! Some do! So is the shingles vaccine suitable for everyone? What are the precautions for vaccination? Don't panic! The answers to your concerns are here! Q1, what are the vaccines currently on the market at home and abroad? A1, at present, there are two kinds of shingles vaccine listed abroad, one for detoxifying live vaccine, one for recombinant protein containing advent vaccine.
    a number of domestic enterprises to carry out research and development of shingles vaccine, and entered the corresponding clinical trial stage, the focus of research and development is mostly detoxifying live vaccine.
    Q2, vaccine adaptation groups? A2, the vaccine can be used for adults 50 years and older to prevent shingles, not for the prevention of primary chickenpox.
    Q3, how effective is the vaccine? A3, foreign clinical trial studies show that in adults aged 50 to 59 years old, the vaccine has a three-year protection effect on shingles of 96.6%, the three-year protection effect of shingles after-effect nerve pain is 100%;
    you get shingles after you get Q4 and vaccination? A4. Existing clinical trial data show that there has been no significant decrease in protection effectiveness in the 4 years after vaccination, but due to the shorter time to market for vaccine development and approval, longer protection time verification needs to be followed by ongoing clinical studies.
    recombinant shingles vaccine can enhance the immune response of the body fluids and induce the immune response of the cells, reducing the prevalence rate.
    vaccine may not have 100% protection effect on all subjects, but the protection effectiveness and duration of the vaccine is limited, similar to other vaccines.
    can I get vaccinated against Q5 and shingles? A5. The recurrence of chickenpox-shingles virus infection occurs in about 20% of serologically positive individuals.
    with an immunodeficiency may develop shingles twice in the same cortical section, with very few cases relapsing several times.
    data are limited on individuals with a history of shingles and on infirm individuals, including those with multiple combined symptoms.
    , the benefits and risks of vaccination must be weighed on an individual basis.
    : Not inoculated when you are in the acute onset of shingles.
    be vaccinated against Q6, children and adults under 50? A6, shingles virus is most common in people over 50 years of age and immunodeficiency, in children and young adults with mild and rare symptoms, therefore, children are not recommended to be vaccinated against shingles.
    of chickenpox virus in children, it is recommended to get chickenpox vaccine.
    Q7, who is not suitable for vaccination? A7, recombinant shingles vaccine drug instructions indicate that its active ingredients or any accessories allergy is prohibited.
    Q8, how is the vaccine vaccinated? A8, vaccine only intramuscular injection, the preferred vaccination site for the upper arm triangular muscle.
    two doses of 0.5mL per dose.
    2 months between the 2nd and 1st doses.
    to change the immunization procedure, the second dose can be given between 2 and 6 months after the first dose.
    adverse reactions to Q9 and vaccination? A9, a clinical randomized double-blind blank control trial for subjects over 50 years of age in many countries around the world showed that the common local adverse reactions after vaccination were pain, redness, swelling, systemic adverse reactions were myalgia, fatigue, headache, chills, fever, gastrointestinal symptoms. although the
    vaccine is listed overseas, but the lack of comprehensive epidemiological data in China, as well as whether the use of new adjuncts will lead to the risk of potential immuno-mediated diseases, its safety, clinical effectiveness data need to be further improved and updated after the market.
    Q10, what do I need to pay attention to inoculation? A101. Vaccination should be postponed if the affected person has acute severe fever and, if only for minor infections such as colds, vaccination should not be postponed.
    2. Vaccines are for preventive purposes only and are not intended to treat clinical diseases that have occurred.
    . Intravenous or intra-skin injections are strictly prohibited, as this may lead to an over-the-caught local reaction.
    . Use with caution in patients with platelet reduction or any coagulation disorder, as bleeding reactions may occur during intramuscular injections in the above-mentioned patients.
    . Fatigue and discomfort may occur after vaccination and may slightly affect driving and operating machine ability within 2 to 3 days.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.